Gossamer Bio Inc
GOSS
NASDAQ
Biotechnology
$0.15
USD
-0.02 (-9.45%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $81.25M
Volume 13.5M
Revenue
$55.54M
TTM
-55.4%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-180.40M
TTM
-252.1%
YoY
Operating Cash Flow
$-170.26M
TTM
-1969.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 9.9 | 11.5 | 13.3 | 13.8 | 17.0 |
YoY Growth | — | -88.0% | +40.2% | +47.1% | +71.5% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 9.9 | 11.5 | 13.3 | 13.8 | 17.0 |
Selling, General & Administrative | 8.7 | 8.7 | 9.4 | 10.9 | 18.7 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 46.7 | 50.3 | 62.4 | 59.8 | 61.8 |
Operating Income | -36.8 | -38.8 | -49.1 | -46.0 | -44.9 |
EBITDA | -36.8 | -38.8 | -49.1 | -52.3 | -44.9 |
Other Income / Expense | 2.6 | 2.7 | 3.0 | 1.0 | 0.6 |
Total Other Income / Expense | 0.2 | 0.5 | 0.9 | -1.3 | -1.8 |
Income Before Income Taxes | -36.6 | -38.3 | -48.2 | -47.3 | -46.7 |
Income Taxes | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 |
Net Income | -36.6 | -38.3 | -48.2 | -47.2 | -46.7 |
Consolidated Net Income / Loss | -36.6 | -38.3 | -48.2 | -47.2 | -46.7 |
Net Income Attributable to Common Shareholders | -36.6 | -38.3 | -48.2 | -47.2 | -46.7 |
Basic EPS | -$0.16 | -$0.17 | -$0.21 | -$0.20 | -$0.20 |
Diluted EPS | -$0.16 | -$0.17 | -$0.21 | -$0.20 | -$0.20 |
Basic Shares Outstanding | 226.8M | 227.3M | 228.0M | 232.0M | 234.1M |
Diluted Shares Outstanding | 226.8M | 227.3M | 228.0M | 232.0M | 234.1M |